| 08/19/2026 4:07 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2026 4:00 PM | Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 4:00 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 9:24 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 3:19 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/13/2026 3:33 PM | Revelation Biosciences (1810560) Filer | Form 8-A12B | |
| 07/13/2026 3:05 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/24/2026 3:47 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/01/2026 4:26 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 10:34 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G | |
| 05/11/2026 8:56 AM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
Get the Latest News and Ratings for REVBW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/11/2026 7:45 AM | Revelation Biosciences (1810560) Filer | Form ARS | |
| 05/07/2026 3:06 PM | Revelation Biosciences (1810560) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 4:31 PM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:32 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 3:31 PM | Revelation Biosciences (1810560) Filer | Form PRE 14A | |
| 04/15/2026 3:13 PM | Revelation Biosciences (1810560) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 8:37 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G/A | |
| 02/17/2026 11:35 AM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
| 02/11/2026 11:15 PM | Revelation Biosciences (1810560) Filer | Form EFFECT | |
| 02/11/2026 4:30 PM | Revelation Biosciences (1810560) Filer | Form 424B3 | |
| 02/05/2026 4:29 PM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:29 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:30 PM | CARVER JENNIFER (1663163) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:30 PM | Chawla Lakhmir S (1646626) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 4:31 PM | Revelation Biosciences (1810560) Issuer ROPER JESS (1408993) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 7:31 PM | Revelation Biosciences (1810560) Subject SABBY MANAGEMENT, LLC (1535610) Filed by | Form SCHEDULE 13G | |
| 01/12/2026 4:21 PM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:12 PM | CARVER JENNIFER (1663163) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:17 PM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:08 PM | Revelation Biosciences (1810560) Issuer ROPER JESS (1408993) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 4:01 PM | Chawla Lakhmir S (1646626) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/03/2025 4:01 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 5:15 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Revelation Biosciences (1810560) Subject | Form SCHEDULE 13G | |
| 11/12/2025 3:10 PM | Revelation Biosciences (1810560) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 11/10/2025 1:57 PM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |
| 10/31/2025 11:54 AM | Revelation Biosciences (1810560) Issuer ROPER JESS (1408993) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 11:55 AM | Revelation Biosciences (1810560) Issuer Zygmont Chester Stanley III (1900657) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 11:56 AM | CARVER JENNIFER (1663163) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 11:58 AM | Revelation Biosciences (1810560) Issuer Rolke James (1693858) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 12:01 PM | Chawla Lakhmir S (1646626) Reporting Revelation Biosciences (1810560) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Before Anthropic becomes impossible to ignore... (Ad) Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9.1 billion dollars, according to CNBC.
Before any Anthropic IPO arrives, one publicly accessible vehicle already lists Anthropic as its largest holding, available through a regular brokerage with no accredited-investor requirement.
History showed how fast access tightened once SpaceX became a headline name. Alexander Green of The Oxford Club says this window is open now. Learn about this early Anthropic access opportunity before it closes |
| 10/31/2025 8:19 AM | Revelation Biosciences (1810560) Filer | Form PRE 14A | |
| 10/15/2025 4:06 PM | Revelation Biosciences (1810560) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 11:15 PM | Revelation Biosciences (1810560) Filer | Form EFFECT | |
| 09/30/2025 4:13 PM | Revelation Biosciences (1810560) Filer | Form 424B3 | |
| 09/22/2025 3:15 PM | Revelation Biosciences (1810560) Filer | Form DEF 14A | |